Viking Therapeutics Inc (0VQA)
LSE
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -112.273 | -13.601 | -8.79 | -14.607 | -23.542 | -36.323 | -31.99 | -17.225 |
| Return on Equity (%) | -191.352 | -14.179 | -8.969 | -15.148 | -24.647 | -39.669 | -34.794 | -17.899 |
| Return on Invested Capital (%) | -184.447 | -16.836 | -11.379 | -16.37 | -24.967 | -40.547 | -40.859 | -24.571 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 0.376 | 4.15 | 3.827 | 3.337 | 2.58 | 1.911 | 3.483 | 7.899 |
| Earnings Per Share | -0.575 | -0.308 | -0.356 | -0.539 | -0.703 | -0.905 | -0.859 | -0.987 |
| Cash Per Share | 0.251 | 0.345 | 0.116 | 0.398 | 0.337 | 0.482 | 0.555 | 0.239 |
| Working Capital Per Share | 0.368 | 4.148 | 3.821 | 3.332 | 2.578 | 1.908 | 3.48 | 7.895 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -0.575 | -0.308 | -0.356 | -0.539 | -0.703 | -0.905 | -0.859 | -0.987 |
| EBITDA Per Share | -0.575 | -0.308 | -0.356 | -0.539 | -0.703 | -0.905 | -0.859 | -0.987 |
| Free Cash Flow Per Share | -0.575 | -0.308 | -0.356 | -0.539 | -0.703 | -0.905 | -0.859 | -0.987 |
| Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 35.82M | 71.74M | 72.41M | 73.22M | 78.25M | 76.06M | N/A | N/A |
| Market Cap | 0 |
| Price to Earnings Ratio | -26.48 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 109.15 |
| Price to Book Ratio | 3.31 |
| Dividend Yield | - |
| Shares Outstanding | 111.44M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
